IKONISYS news, videos and press releases
For more news please use our advanced search feature.
IKONISYS - More news...
IKONISYS - More news...
- Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy
- Ikonisys Finalized a Capital Increase Through a Private Placement
- Ikonisys’ Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia
- Ikonisys Secures U.S. Patent for “Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments”
- Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina
- Ikonisys finalized a capital increase through the offsetting of debt
- Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific
- The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC”
- Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy
- Ikonisys Completed a Capital Increase Through a Private Placement
- Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama
- Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety
- Ikonisys Announces the Completion of New Financing via the Issuance of a €0.5m Private Note
- Ikonisys presents an update of its global activity in the context of its recent technological and commercial milestones
- Ikonisys Announces the Successful Deployment of the Commercial Strategy With the Second Sale of the Ikoniscope20max Solution
- Half-Yearly Report on the Ikonisys Liquidity Contract at 30/06/2023
- Ikonisys Announces the Results of Its Ordinary Annual and Extraordinary General Meeting of June 28, 2023
- Ikonisys Announces the First Sale of the Ikoniscope20max Solution
- Ikonisys Announces the Completion of a Private Placement to Accelerate Its Commercial Development
- Ikonisys SA: Terms and Conditions of Availability of Preparatory Documents for the General Meeting of June 28, 2023
- Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments
- Ikonisys and Integrated Gulf Biosystems Group enter into Distribution Collaboration for Distribution of the Ikoniscope20 System in the Middle East Market
- Ikonisys Announces the Launch of Its Instrument for High-Volume Customers, the Ikoniscope20max
- Ikonisys Publishes Its 2022 Half-Year Financial Results and Reviews Its Operational Deployments
- Ikonisys Announces the Installation of the Ikoniscope20 Solution at a US Leading Urology Laboratory
- Ikonisys Announces the Start of a Distribution Collaboration with BioVendor Laboratory Medicine for Distribution of the Ikoniscope20 System in the Eastern European Market
- Ikonisys Reinforces Its Strategic Collaboration With Empire Genomics Following Excellent Results of Optimized Reagents in Detection of Bladder Cancer Cells
- Ikonisys Announces the First Sale of the Ikoniscope20 Solution Including the Newly Added Reagents to Comprehensive Urology
- Ikonisys Announces the First Sale of the Ikoniscope20 Solution Including the Newly Added Reagents to Comprehensive Urology
- Ikonisys Signs Contract and Initiates Research Activities With Politecnico Di Milano, a World Leading Public Scientific-technological University in the Field of Computer Science and Bioengineering
